Ovid Therapeutics Inc. announced that Douglas E. Williams, Ph.D., has joined the company's board of directors, effective immediately. Dr. Williams, the founding Chief Executive Officer of Codiak Biosciences and former Executive Vice President, Research and Development at Biogen, possesses more than 25 years of scientific and senior leadership experience within the life sciences industry. Dr. Williams is President, CEO, and member of the Board of Directors of Codiak Biosciences.

Previously, he served as Biogen's Executive Vice President, Research and Development. He joined Biogen from ZymoGenetics, where he was most recently CEO and member of the Board of Directors. Prior to this role, Dr. Williams held senior leadership positions within the biotechnology industry, including Chief Scientific Officer and Executive Vice President of Research and Development at Seattle Genetics, and Senior Vice President and Washington Site Leader at Amgen.

Dr. Williams also served in a series of scientific and senior leadership positions over a decade at Immunex, including as Executive Vice President, Chief Technology Officer, and a member of the Board of Directors.